KR101328413B1 - An extracting method of ginseng by high pressure/enzyme decomposition - Google Patents
An extracting method of ginseng by high pressure/enzyme decomposition Download PDFInfo
- Publication number
- KR101328413B1 KR101328413B1 KR1020110092204A KR20110092204A KR101328413B1 KR 101328413 B1 KR101328413 B1 KR 101328413B1 KR 1020110092204 A KR1020110092204 A KR 1020110092204A KR 20110092204 A KR20110092204 A KR 20110092204A KR 101328413 B1 KR101328413 B1 KR 101328413B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- enzyme
- weight
- high pressure
- pressure
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 84
- 241000208340 Araliaceae Species 0.000 title claims abstract description 83
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 82
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 82
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 51
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000000354 decomposition reaction Methods 0.000 title claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000000605 extraction Methods 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 235000002789 Panax ginseng Nutrition 0.000 description 25
- 229930182490 saponin Natural products 0.000 description 24
- 235000017709 saponins Nutrition 0.000 description 24
- 150000007949 saponins Chemical class 0.000 description 23
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 22
- 239000007787 solid Substances 0.000 description 17
- 238000003809 water extraction Methods 0.000 description 16
- 229930182494 ginsenoside Natural products 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 14
- 229940089161 ginsenoside Drugs 0.000 description 13
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 12
- 241000723346 Cinnamomum camphora Species 0.000 description 12
- 229960000846 camphor Drugs 0.000 description 12
- 229930008380 camphor Natural products 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000006862 enzymatic digestion Effects 0.000 description 5
- 241000209219 Hordeum Species 0.000 description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- 108090001109 Thermolysin Proteins 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 235000020710 ginseng extract Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- RDIMTXDFGHNINN-UHFFFAOYSA-N (3R,9R,10R)-1-heptadecen-4,6-diyne-3,9,10-triol Natural products CCCCCCCC(O)C(O)CC#CC#CC(O)C=C RDIMTXDFGHNINN-UHFFFAOYSA-N 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 206010057672 Male sexual dysfunction Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 2
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- RDIMTXDFGHNINN-IKGGRYGDSA-N panaxytriol Chemical compound CCCCCCC[C@H](O)[C@@H](O)CC#CC#C[C@H](O)C=C RDIMTXDFGHNINN-IKGGRYGDSA-N 0.000 description 2
- ZCKMUKZQXWHXOF-UHFFFAOYSA-N panaxytriol Natural products CCC(C)C(C)C(C)C(C)C(C)C(O)C(O)CC#CC#CC(O)C=C ZCKMUKZQXWHXOF-UHFFFAOYSA-N 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- -1 triterpenoid dammarane saponin Chemical class 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- 150000004823 xylans Chemical class 0.000 description 2
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 101800000112 Acidic peptide Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- GVLDSGIQZAFIAN-UHFFFAOYSA-N Panaxydol Natural products CCCCCCCC1OC1CC#CC#CC(O)C=C GVLDSGIQZAFIAN-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- GVLDSGIQZAFIAN-IXDOHACOSA-N panaxydol Chemical compound CCCCCCC[C@@H]1O[C@@H]1CC#CC#C[C@H](O)C=C GVLDSGIQZAFIAN-IXDOHACOSA-N 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000036967 uncompetitive effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 물 중량 대비 20중량% 내지 30중량%의 수삼을 가하고, 기질대비 0.5중량% 내지 1.2중량%의 효소를 고압반응기에 첨가하고, 55℃ 내지 60℃의 온도로 조절하면서, 고압반응기를 100MPa 내지 200MPa로 조절하여 24시간 내지 48시간 유지하여 인삼류 유용성분을 추출하는 고압효소분해에 의한 인삼류 유용성분의 추출 방법을 제공한다.In the present invention, 20% to 30% by weight of ginseng is added to the weight of water, 0.5% to 1.2% by weight of the enzyme is added to the high pressure reactor, and the high pressure reactor is adjusted to a temperature of 55 ° C to 60 ° C. The present invention provides a method for extracting useful components of ginseng by autoclaving to extract useful components of ginseng by maintaining 100 to 200 MPa for 24 to 48 hours.
Description
본 발명은 고압/효소분해에 의한 인삼류 유용성분의 추출방법에 관한 것이다. 더욱 상세히, 본 발명은 수삼, 홍삼, 및 장뇌삼으로부터 고압/효소분해에 의하여 사포닌 함량을 98%이상 추출하여 인삼음료를 제조하는 방법에 관한 것이다.The present invention relates to a method for extracting useful components of ginseng by high pressure / enzymatic digestion. More specifically, the present invention relates to a method for producing ginseng drink by extracting more than 98% saponin content by high pressure / enzymatic digestion from ginseng, red ginseng, and camphor ginseng.
한국 인삼(Panax ginseng C. A. Meyer, family Araliaceae) 은 동양에서 수 천년 동안 신비한 효능을 제공하는 약용식물로 이용되어 오고 있고 있으며, 특히 한국, 일본 및 중국에서는 가장 효용가치가 있는 약용식물로 평가되고 있다. 인삼의 대표적인 약리작용은 중추신경계, 심혈관계, 내분비계 및 면역계에 대하여 활성증진 효과를 제공함으로써 항암, 심장질환, 노화지연 및 성인병 치료 등의 목적으로 이용되고 있다. 현재 인삼은 뇌증진 항진효능, 암예방과 항암활성 효능, 면역기능 증강 효능, 항당뇨 효능, 간기능 항진 효능, 항피로 및 항스트레스 효능, 여성 갱년기장해 개선 효능, 남성 성기능장해 개선 효능, AIDS 바이러스 증식억제 효능, 항산화 활성 및 노화억제 효능 등과 같은 다양한 약리효능을 발휘하는 최고의 천연약재로 인식되면서 세계시장 수요도 증가하고 있다. 인삼의 약리활성 성분의 약리작용을 요약하면 [표 1]과 같다. Korean Ginseng ( Panax ginseng CA Meyer, family Araliaceae) has been used as a medicinal plant in the Orient for thousands of years, and is regarded as the most valuable medicinal plant in Korea, Japan and China. The representative pharmacological action of ginseng is used for the purpose of treating cancer, heart disease, aging delay and adult disease by providing activity promoting effect on the central nervous system, cardiovascular system, endocrine system and immune system. Ginseng currently has anti-cancer effect, anti-cancer and anti-cancer activity, immune-enhancing effect, anti-diabetic effect, hepatic function-enhancing effect, anti-fatigue and anti-stress effect, improvement of menopausal disorders, improvement of male sexual dysfunction, AIDS virus As it is recognized as the best natural medicine that exhibits various pharmacological effects such as anti-proliferative effect, antioxidant activity and anti-aging effect, the global market demand is increasing. The pharmacological action of the pharmacologically active component of ginseng is summarized in [Table 1].
G-Rb1, G-Rg1, G-Rg2
G-Rb1, G-Rg1, G-Rg2
학습기능증진, 기억력 감퇴개선
Learning function improvement, memory decline
Zhang et al. 1990Saito et al. 1988
Zhang et al. 1990
40% 에탄올 인삼추출물Panaxatriol-based saponins
40% Ethanol Ginseng Extract
지적 작업수행효율 향상
Improved intellectual work performance
Dangelo 1996Park et al. 1994
Dangelo 1996
G-Rh2, polyacetylene 화합물
(panaxydol, panaxynol, panaxy-
triol)
G-Rh2, polyacetylene compound
(panaxydol, panaxynol, panaxy-
triol)
암세포 증식억제
Cancer cell proliferation inhibition
Matsunaga et al. 1990
Kikuchi et al. 1991
Odasshima et al. 1979
Hwang 1993Ahn et al. 1987
Matsunaga et al. 1990
Kikuchi et al. 1991
Odasshima et al. 1979
Hwang 1993
G-Rb2, acidic peptide, adenosine, pyroglutamic acid
G-Rb2, acidic peptide, adenosine, pyroglutamic acid
항당뇨
Antidiabetic
Okuda et al. 1990
Takaku et al. 1990
Ando et al. 1979Yokozawa et al. 1985
Okuda et al. 1990
Takaku et al. 1990
Ando et al. 1979
G-Rb1, G-Rg1, G-Rf, G-Ro,
인삼추출물
G-Rb1, G-Rg1, G-Rf, G-Ro,
Ginseng Extract
간기능 항진
Hepatic hyperactivity
Mizoguchi et al. 1988
Huh et al. 1988
Lee et al. 1984
Okamura et al. 1994
Matsuda et al. 1991Song et al. 1990
Mizoguchi et al. 1988
Huh et al. 1988
Lee et al. 1984
Okamura et al. 1994
Matsuda et al. 1991
G-Rg1
G-Rg1
항피로 및 항스트레스 효능
Anti-fatigue and antistress efficacy
Kim 1979
Kaneko et al. 1996Saito et al. 1984
Kim 1979
Kaneko et al. 1996
G-Rg1, 홍삼 추출물
G-Rg1, Red Ginseng Extract
남성 성기능 장해 개선
Improve male sexual dysfunction
Choi et al. 1995Saito et al. 1984
Choi et al. 1995
조 사포닌
Joe Saponin
AIDS 바이러스 증식억제
AIDS virus growth inhibition
Cho et al. 1993Shin et al. 1993
Cho et al. 1993
폴리페놀 및 polyacetylene 화합물
Polyphenols and polyacetylene compounds
항산화 및 노화억제
Antioxidant and Anti Aging
Kim et al. 1988
Chung et al. 1993
Wang et al. 1994Han et al. 1985
Kim et al. 1988
Chung et al. 1993
Wang et al. 1994
인삼에 있어 중요성분은 진세노사이드(ginsenoside) 배당체(glycoside)로서 다른 식물체에서 얻어지는 사포닌과는 다른 특성을 갖는다. 즉, 인삼 사포닌은 triterpenoid dammarane saponin 으로 인삼 속 식물에만 존재하며, 약리적 작용이 다른 약용식물의 사포닌과는 전혀 다르다. 대표적인 진세노사이드의 분자량을 살펴보면 다음과 같다. An important ingredient in ginseng is ginsenoside glycoside, which has different characteristics from saponins obtained from other plants. In other words, ginseng saponin is a triterpenoid dammarane saponin, which exists only in the plant of ginseng, and its pharmacological action is completely different from that of other medicinal plants. Looking at the molecular weight of the typical ginsenosides are as follows.
Ginsenoside-Rg1 (C42H72O142H2O): 837Ginsenoside-Rg 1 (C 42 H 72 O 14 2H 2 O): 837
Ginsenoside-Rb1 (C54H92O233H2O): 1163 Ginsenoside-Rb 1 (C 54 H 92 O 23 3H 2 O): 1163
Ginsenoside-Rf (C42H72O142H2O): 837Ginsenoside-rf (C 42 H 72 O 14 2H 2 O): 837
배당체는 산으로 가수분해하면 유리당과 aglycone으로 분리되는데, panaxadiol, panaxatriol 및 oleanolic acid가 인삼 진세노사이드의 aglycone이다.Glycosides are hydrolyzed into acids to separate free sugars and aglycones. Panaxadiol, panaxatriol and oleanolic acid are aglycones of ginseng ginsenosides.
한편, 홍삼은 수삼이나 백삼에 존재하지 않는 홍삼 특유의 새로운 약효성분이 생성되거나 일부 활성성분의 함량이 증가하는 것으로 보고되었다. 그러나, 홍삼 또는 흑삼은 원료 수삼을 증자하여 건조를 1-9회 실시하여 제조하는데, 증숙과정에서 증기에너지가 투입되고, 건조과정에서는 열풍건조, 마이크로파 건조, 냉풍건조 및 원적외선 건조방법 등과 같은 건조에너지가 소요되는 고 에너지 소비공정으로 생산되고 있다 (도 1 참조).On the other hand, red ginseng has been reported to produce new active ingredients unique to red ginseng or white ginseng, or increase the content of some active ingredients. However, red ginseng or black ginseng is manufactured by increasing the raw ginseng and drying it 1-9 times. Steam energy is input during steaming, and drying energy such as hot air drying, microwave drying, cold air drying and far-infrared drying methods in the drying process. Has been produced in a high energy consumption process (see FIG. 1).
또한, 증숙과정에서 백피현상과 터짐현상 등이 발생하여 품질저하를 초래함으로서 상품성을 잃고, 증숙기 하부에 증숙액이 유출되어 유효성분의 손실이 발생하는 중요한 문제가 있다.In addition, there is an important problem that loss of commerciality by loss of merchandise, leakage of steaming liquid in the lower part of the steamer and the loss of quality due to the degradation of the quality caused by the phenomenon of back skin phenomenon and burst phenomenon in the steaming process.
본 발명은 현행 홍삼제조 공정의 비효율성 및 비경제성을 해결할 수 있는 방법으로서 고압조건에서 수삼을 분해 및 분리할 경우 수삼에 함유된 총 ginsenoside 함량을 홍삼 대비 50-120% 이상 증가시킬 수 있는 기술이다(표 9참조). 따라서, 고압처리 기술을 인삼류 유용성분의 추출 공정에 적용한다면 현행 홍삼제조의 단점을 개선할 수 있는 저에너지 및 고생산성의 위생적인 경제적인 공정이 될 수 있는 것이 특징이다. The present invention is a method to solve the inefficiency and economic efficiency of the current red ginseng manufacturing process is a technology that can increase the total ginsenoside content contained in fresh ginseng 50-120% or more compared to red ginseng under high pressure conditions (See Table 9). Therefore, if the high-pressure treatment technology is applied to the extraction process of ginseng useful ingredients, it can be a hygienic economic process of low energy and high productivity that can improve the disadvantages of the current red ginseng manufacturing.
이와 관련하여, 식품고압기술에 대한 국내 및 국외 특허 및 논문의 내용은 대부분이 저온살균 위주의 기술로서, 기술적용 내용을 살펴보면 압력은 30-700 MPa, 고압처리 시간은 1-5분 범위에서 수행하고 있다.In this regard, most of the domestic and foreign patents and papers on food high pressure technology are pasteurization-oriented technologies. Looking at the technical contents, the pressure is 30-700 MPa and the high-pressure treatment time is 1-5 minutes. Doing.
고압기술을 식물 생리활성 성분의 추출, 분리 및 식물 세포벽을 분해하기 위한 추출분해 기술로 활용하기 위한 시도가 보고되었으나, 고압시스템 고압용기의 내압성이 낮아 처리시간이 30분을 초과하지 못하고 있는 실정이다. 저온상태에서 식물성 성분의 추출율 및 분해율을 높이기 위하여는 최소 4시간 정도의 압력처리가 요구되거나 효소분해 반응을 유도할 경우 24시간 까지도 400 MPa 이상의 압력을 유지할 수 있는 시스템이 요구되고 있으나, 일부 특허 및 논문의 결과는 압력용기의 제한된 내압성의 단점을 보완하기 위하여 초음파, 전기장 및 고온처리를 병행하는 고압기술을 보고하였는데 이러한 기술은 저에너지 및 저탄소 생산기술이 요구되는 세계적인 기술경쟁 시대에서 경쟁력이 없는 것으로 판단된다. Attempts have been made to utilize high pressure techniques as extraction and separation techniques for the extraction and separation of plant bioactive components and to decompose plant cell walls, but the treatment time does not exceed 30 minutes due to the low pressure resistance of the high pressure system. . In order to increase the extraction rate and decomposition rate of vegetable components at low temperature, a pressure treatment of at least 4 hours is required, or a system capable of maintaining a pressure of 400 MPa or more up to 24 hours when inducing an enzymatic decomposition reaction is required. The results of this paper report high pressure technology that combines ultrasonic, electric field and high temperature treatment to make up for the shortcomings of the limited pressure resistance of pressure vessels. These technologies are considered to be uncompetitive in the era of global technological competition requiring low energy and low carbon production technology. do.
본 발명에서는 저에너지를 사용하여 인삼류의 유용성분을 추출함에 있어, 보다 경제적인 방법을 제안하고자 한다. In the present invention, to extract useful components of ginseng using a low energy, to propose a more economic method.
본 발명에 따른 인삼류 유용성분의 추출방법은 다음과 같다.Extraction method of the useful components of ginseng according to the present invention is as follows.
종래 고압기술은 700-1000 MPa 범위의 초고압 조건으로 유해 미생물의 살균 및 멸균목적으로 산업적으로 이용해 오고 있다. 그러나 최근 식품분야에서 고압기술은 식품 생산공정에 있어 살균 또는 멸균 목적의 범주를 벗어나 비가열 처리방법의 하나로 50℃ 이하의 온도에서 식품 영양소 및 고유성분의 파괴나 손실없이 기능성 식품원료를 저분자화 용해하거나 추출하는 목적으로 활용할 수 있는 기술이 시도되고 있다. 특히 고압처리에 의하여 수용화 및 추출율 증대 효과로 저분자화한 생리활성 물질은 인체의 소화흡수율을 극대화함은 물론 유용 성분의 색상, 향미, 영양성분 등을 유지할 수 있는 장점이 부각되면서 기존 가열처리 공정에 의한 제품과 비교시 기능 특성이 차별화된 제품을 생산할 수 있다. 따라서, 50-500 MPa의 고압 및 50℃의 온도에서 처리대상 원료의 분해에 적절한 효소를 작용시켜 분해할 경우 종래 가열처리 공정에 비하여 고품질의 추출 및 분해물을 생산하는데 있어 생산성 및 효율성을 증진시킬 수 있다.Conventional high pressure technology has been industrially used for the sterilization and sterilization of harmful microorganisms under ultrahigh pressure conditions in the range of 700-1000 MPa. In recent years, however, high pressure technology in the food field is one of the non-heating treatment methods beyond the scope of sterilization or sterilization in the food production process and low molecular dissolution of functional food raw materials without destroying or losing food nutrients and intrinsic ingredients at temperatures below 50 ℃. Techniques that can be utilized for the purpose of extracting or extracting are being attempted. In particular, biomolecules that have been made low-molecularly by increasing the solubility and extraction rate by high pressure treatment can maximize the digestive absorption rate of the human body and maintain the color, flavor, and nutritional value of useful ingredients. Compared with the product, it is possible to produce a product with different functional characteristics. Therefore, when decomposing by applying an enzyme suitable for the decomposition of the raw material at a high pressure of 50-500 MPa and a temperature of 50 ℃ can improve the productivity and efficiency in producing high quality extraction and decomposition products compared to the conventional heat treatment process. have.
고압조건 300 MPa에서 단백질 분해효소 trypsin은 상압조건보다 활성이 40% 증가하였으나, thermolysin의 경우는 잔존활성이 5% 이하를 보이는 것과 같이 효소의 내압특성은 효소의 작용기작과 밀접한 관계가 있다. 즉, trypsin과 thermolysin효소의 활성부위 구조를 비교해 보면 serine계 단백질 분해효소인 trypsin의 활성부위에는 고유결합만 존재하므로 고압조건에서 파괴되지 않는 반면, metalloprotease의 한 종류인 thermolysin은 아연(Zn)이온이 배위결합에 의하여 활성부위의 아미노산인 histidine과 glutamic acid와 결합을 할 뿐만 아니라 효소의 촉매작용에 있어서 중요한 역할을 한다. 따라서 고압처리는 아연에 의한 배위결합을 파괴하고 그 결과로서 thermolysin은 효소활성을 잃게 되는 것으로 보고되었다(김남수 외, 2010, 한국식품연구원 보고서). At 300 MPa under high pressure, protease trypsin showed 40% more activity than normal pressure, but thermolysin showed less than 5% residual activity, so the pressure resistance of enzyme was closely related to the mechanism of action. In other words, comparing the structure of the active site of trypsin and thermolysin enzyme, the active site of trypsin, a serine protease, does not destroy under high pressure conditions because only unique bonds exist, whereas thermolysin, a type of metalloprotease, is a zinc (Zn) ion. Coordination bonds not only bind the active sites amino acids histidine and glutamic acid, but also play an important role in catalysis of enzymes. Therefore, high-pressure treatment destroys the coordination bonds by zinc, and as a result, thermolysin has been reported to lose enzymatic activity (Kim Nam-su et al., 2010, Korea Food Research Institute).
수삼과 물의 비율은 물에 대한 수삼비율을 20중량% 내지 30중량%로 한다. 이와 같은 수치한정이유는 이하의 실시예에서 확인되는 바와 같이 이 범위에서 수용성 고형분과 수용성 총사포닌의 추출비율이 가장 높았기 때문이다. 이하 같다.The ratio of fresh ginseng and water is 20 to 30% by weight of the ratio of fresh ginseng to water. Such numerical limitation is because the extraction ratio of water-soluble solids and water-soluble total saponin was the highest in this range, as confirmed in the following examples. The same shall apply hereinafter.
효소 농도는 수삼에 대하여 0.5중량% 내지 1.2중량%로 사용한다. 이 중량%는 수삼에 대한 중량 대비이다. 효소는 전체 원료로 사용되는 수삼에 대하여 보리엿기름 0.1중량% 내지 3중량%, 전분, 셀루로오스, 및 탄수화물 가수분해효소 0.3중량% 내지 3중량%로 이루어지는 복합효소를 사용한다. 현재 이러한 효소로 시판되는 것에는 Thermamyl, Viscozyme, 및 Cellulast가 있다. 효소는 상기한 바와 같이 수삼대비 0.5 내지 1.2중량%가 되도록 사용한다. 효소는 보리엿기름을 기본으로 하고 나머지 세가지 효소중 하나 또는 그 이상을 사용할 수 있는데, 바람직하게는 세 가지 효소를 모두 포함한다. 이상과 같은 복합효소로 한정한 이유는 현재 식품용의 상업용 효소로 알려져 있는 것을 사용한 것이고, 이 4가지 효소로 98% 이상의 분해율을 보여 경제성을 고려할 때 효소를 추가할 필요성이 없을 것으로 판단되었기 때문이다. .Enzyme concentration is used at 0.5% to 1.2% by weight based on fresh ginseng. This weight percentage is relative to the weight for fresh ginseng. The enzyme uses a complex enzyme consisting of 0.1% to 3% by weight of barley malt oil, starch, cellulose, and 0.3% to 3% by weight of carbohydrate hydrolase, based on fresh ginseng used as a whole raw material. Current commercially available such enzymes include Thermamyl, Viscozyme, and Cellulast. The enzyme is used to be 0.5 to 1.2% by weight relative to ginseng as described above. The enzyme is based on barley malt and may use one or more of the other three enzymes, preferably all three enzymes. The reason for limiting to the above-mentioned complex enzyme is that it is currently used as a commercial enzyme for food, and since these four enzymes showed a decomposition rate of more than 98%, it was judged that there was no need to add enzyme in consideration of economic efficiency. . .
상기의 물, 수삼 및 효소를 고압반응기에 넣고 압력을 가할 때의 압력은 100MPa 내지 200MPa로 조절한다.When the water, fresh ginseng, and the enzyme are put into a high pressure reactor and pressure is applied, the pressure is adjusted to 100 MPa to 200 MPa.
압력의 처리시간은 24시간 내지 48시간으로 한다.The treatment time of the pressure is 24 hours to 48 hours.
고압효소 분해의 온도는 55℃ 내지 60℃로 한다.The high pressure enzyme decomposition temperature is 55 ℃ to 60 ℃.
이상의 공정조건 중 인삼류의 유용성분을 가장 경제적으로 추출할 수 있는 조건은, 이하의 실시예에서 확인되는 바와 같이, 효소 사용량 0.6%, 100MPa의 압력, 24시간, 및 55℃의 고압조건이다.Among the above process conditions, the most economically extractable useful ingredients of ginseng are 0.6% enzyme, 100 MPa pressure, 24 hours, and 55 ° C high pressure conditions, as confirmed in the following examples.
본 발명에서 제안하는 고압효소분해 기술은 저에너지를 사용하여 인삼류의 유용성분을 가장 높은 추출율로 추출할 수 있어, 이를 이용하여 인삼음료를 제공할 수 있는 잇점이 있다. 또한 본 발명에 따른 고압효소분해 기술은 기존의 홍삼제조공정과 비교할 때, 도 1에서 확인되는 바와 같이 제조 단가가 1/10의 저렴한 비용으로 제조할 수 있어 경제적인 효과가 뛰어난 것으로 판단된다. The high pressure enzymatic decomposition technique proposed by the present invention can extract useful components of ginseng at the highest extraction rate using low energy, thereby providing a ginseng beverage using the same. In addition, the high-pressure enzyme decomposition technology according to the present invention is compared with the conventional red ginseng manufacturing process, as shown in Figure 1 can be manufactured at a low cost of 1/10 of the manufacturing cost is judged to be excellent economic effect.
도 1은 현행 홍삼제조공정을 나타내고 이 방법과 본 발명에 따른 공정에 있어서의 소요비용을 비교한 도시이다.Figure 1 shows the current red ginseng manufacturing process and compares the required cost in this method and the process according to the present invention.
이하, 본 발명을 본 발명이 속하는 기술분야에서 통상의 지식을 가지는 자각 용이하게 실시할 수 있도록 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail so that the present invention can be easily realized with ordinary knowledge in the art. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
본 발명에서 사용한 인삼은 2009년산 충남 금산 지역에서 재배한 수삼(4, 5, 6년근)을 사용하였고, 홍삼은 상기 수삼중 일부를 현행 홍삼제조 방법과 동일한 조건으로 제조하여 사용하였다. 장뇌삼은 충남 금산 지역에서 재배한 장뇌삼(3, 5, 7년근)을 사용하였다. 본 발명에 사용한 인삼원료의 일반성분 분석결과를 [표 2]에 나타내었다.The ginseng used in the present invention was used ginseng (4, 5, 6 years old) cultivated in 2009 Geumsan region Chungnam, red ginseng was prepared by using some of the ginseng under the same conditions as the current manufacturing method. The camphor used ginseng (3, 5, 7 years old) grown in Geumsan, Chungnam province. Table 2 shows the results of the general component analysis of ginseng raw materials used in the present invention.
이하 실시예에서는 수삼을 중심으로 설명하였지만, 본 발명자들의 연구에 의하면, 홍삼, 장뇌삼, 및 산삼에서도 유사한 결과를 얻을 수 있었다.In the following examples, the description was made mainly on fresh ginseng, but according to the present inventors, similar results were obtained in red ginseng, camphor ginseng, and wild ginseng.
[실시예 1] : 본 발명에 따른 고압효소분해의 처리방법[Example 1]: Method for Treating Autoclave According to the Present Invention
인삼을 고압조건에서 기질을 분해하기 위하여 사용한 효소원은 전분분해용으로 보리엿기름(시판품, 함양농협) 및 Thermamyl 120L(Novo Nordisk, Denmark)을 사용하였고, 셀룰로오스, 헤미셀룰로오스, 자일란 및 글루칸 분해용으로 Viscozyme L(Novo Nordisk, Denmark)을 사용하였으며, 셀룰로오스 및 자일란 분해용으로 Cellulast 1.5L(Novo Nordisk, Denmark)을 사용하였다. 인삼분해물 제조를 위한 비교군은 수삼 및 홍삼을 100℃에서 3시간 추출한 추출물로 하였다. 본 발명에 적용한 복합효소를 사용한 인삼의 고압효소분해는 기질 중량에 보리엿기름 0.2중량%, Thermamyl 0.1중량%, Viscozyme 0.2중량%, Cellulast 0.1중량%를 가하고, pH를 7.0으로 조정한 후, 반응압력(25, 50, 75, 100, 125, 150, 175, 200 MPa)과 반응시간(4, 8, 12, 24, 32, 48시간) 및 반응온도 (40, 45, 50, 55, 60℃)에 따라 분해를 실시하고, 반응종료 후 원심분리(11,000g, 10분, 4℃)를 통하여 가수분해액과 잔사물질을 획득하였다. 압력 100MPa 및 온도 50℃에서 24시간 분해하고 효소를 불활성화(95℃, 10분)시킨 후 상등액을 분리하여 인삼 추출물로 하였다. 이하의 실시예에서 확인되는 바와 같이, 경제성까지 고려하였을 때, 최적의 조건은 0.6%의 효소첨가량에서 물에 대한 수삼 비율 25%, 100MPa, 55℃, 24시간의 조건이었다. 이하의 표 3 내지 8까지 에서 %는 중량%를 의미한다.Enzyme source used to decompose the substrate in the high-pressure conditions, the ginseng is barley malt for starch degradation (commercial product, cultivating NACF) and Thermamyl 120L was used (Novo Nordisk, Denmark), cellulose, hemicellulose, xylan and glucan as Viscozyme for decomposition L (Novo Nordisk, Denmark) was used and Cellulast 1.5L (Novo Nordisk, Denmark) was used for cellulose and xylan digestion. Comparative group for the production of ginseng degradation product was the extract extracted three times at 100 ℃ ginseng and red ginseng. High-pressure enzymatic digestion of ginseng using the complex enzyme applied to the present invention was performed by adding 0.2% by weight of barley malt oil, 0.1% by weight of thermamyl, 0.2% by weight of Viscozyme, and 0.1% by weight of Cellulast, and adjusting the pH to 7.0. (25, 50, 75, 100, 125, 150, 175, 200 MPa), reaction time (4, 8, 12, 24, 32, 48 hours) and reaction temperature (40, 45, 50, 55, 60 ℃) The decomposition was carried out according to, and the hydrolysis solution and the residue were obtained through centrifugation (11,000 g, 10 minutes, 4 ° C.) after the completion of the reaction. After decomposition for 24 hours at a pressure of 100MPa and a temperature of 50 ℃, the enzyme was inactivated (95 ℃, 10 minutes) and the supernatant was separated to make a ginseng extract. As can be seen from the following examples, considering economics, the optimum conditions were 25% of ginseng to water ratio, 100 MPa, 55 ° C., and 24 hours at an enzyme addition amount of 0.6%. In the following Tables 3 to 8,% means weight%.
* 압력: 100 MPa, 압력처리시간: 24 시간, 온도: 55℃, 복합효소농도 0.6%* Pressure: 100 MPa, Pressure treatment time: 24 hours, Temperature: 55 ℃, Complex enzyme concentration 0.6%
* 압력: 100 MPa, 압력처리시간: 24 시간, 온도: 55℃, 물에 대한 수삼비율: 25%
* Pressure: 100 MPa, Pressure treatment time: 24 hours, Temperature: 55 ℃, Ginseng ratio to water: 25%
*수삼과 물의 비율: 25%, 압력처리시간: 24 시간, 온도: 55℃, 복합효소농도 0.6%* Ratio of fresh ginseng and water: 25%, pressure treatment time: 24 hours, temperature: 55 ℃, complex enzyme concentration 0.6%
* 압력: 수삼과 물의 비율: 25%, 압력: 100 MPa, 온도: 55℃, 복합효소농도 0.6%* Pressure: Fresh ginseng and water: 25%, Pressure: 100 MPa, Temperature: 55 ℃, Complex enzyme concentration 0.6%
*수삼과 물의 비율: 25%, 압력: 100 MPa, 압력처리시간: 24 시간, 복합효소농도 0.6%* Ratio of fresh ginseng and water: 25%, pressure: 100 MPa, pressure treatment time: 24 hours, complex enzyme concentration 0.6%
수삼, 홍삼 및 장뇌삼의 고압효소 분해 후 고형분, 수용성 사포닌 및 추출수율을 [표 8]에 나타내었다. 수삼의 경우, 본 발명에 따른 고압효소분해 후 대조구 열수추출물과 비교시 수용성고형분 함량은 재배기간에 상관없이 약 2.1-2.4배 정도 증가한 결과를 보였다. 추출수율도 고압효소 분해 후 대조구 열수추출물 대비 1.9-2.2배 증가하였으며, 수용성 총사포닌 함량도 1.6배 이상 증가하여 고압효소 분해가 열수추출보다 수삼의 분해에 효과적임을 알 수 있다. 한편, 수용성 총사포닌 함량은 수삼의 재배년수에 비례하여 증가하는 경향을 보여, 재배기간이 길수록 총사포닌 함량이 증가하는 것으로 예측된다. 홍삼의 경우 고압효소 분해 후 대조구 열수추출물과 비교시 수용성 고형분은 1.5-1.9배, 추출수율은 1.6-2.1배 정도 증가하였으며, 수용성 총사포닌 함량도 1.2-1.7배 증가하여 수삼의 경우와 비슷한 경향을 보였다. 한편, 장뇌삼은 수삼과 홍삼보다 고압효소 분해후 열수추출 대비 수용성 고형분과 추출수율이 높아 각각 2.6-3.0배 및 2.4-3.1배 증가한 결과를 나타내었다. 특히 장뇌삼의 수용성 총사포닌 함량은 고압효소분해후 열수추출 대비 1.6-1.7배 증가하였으나 고압효소분해 후 함유량은 가장 높았다. The solid content, water soluble saponin, and extraction yield of high-density enzyme decomposition of fresh ginseng, red ginseng, and camphor ginseng are shown in [Table 8]. In the case of fresh ginseng, the water-soluble solids content was increased by about 2.1-2.4 times regardless of the growing period, compared to the control hot water extract after autoclaving according to the present invention. The extraction yield also increased 1.9-2.2 times compared to the control hot water extract after high pressure enzyme digestion, and the water soluble total saponin content also increased by 1.6 times, indicating that the high pressure enzyme digestion was more effective than the hot water extract. On the other hand, the water-soluble total saponin content tends to increase in proportion to the number of years of growing ginseng, it is expected that the total saponin content increases with longer growing period. In the case of red ginseng, water soluble solids increased 1.5-1.9 times, extraction yield 1.6-2.1 times, and water-soluble total saponin contents increased 1.2-1.7 times compared to control hot water extract after autoclaving. Seemed. On the other hand, camphor ginseng showed higher soluble solid content and extraction yield compared to hot water extraction after decomposing high-pressure enzyme than fresh ginseng and red ginseng, resulting in 2.6-3.0 and 2.4-3.1 times increase respectively. In particular, the water-soluble total saponin content of camphor ginseng was 1.6-1.7 times higher than that of hot water extract after high-pressure enzymatic digestion.
고형분(%)receptivity
Solid content (%)
총사포닌(%)receptivity
Total Saponin (%)
(%)yield
(%)
Red ginseng
수삼, 홍삼 및 장뇌삼의 고압효소분해 후 ginsenoside 함량을 [표 9]에 나타내었다. 수삼의 고압효소 분해후 열수추출 대비 총 ginsenoside 함량을 비교하면, 4, 5 및 6년근에서 각각 17.6, 46.9 및 13.7% 증가한 결과를 보였으며, 홍삼의 경우는 4, 5 및 6년근이 각각 55.5, 10.8 및 2.8%로 총 ginsenoside 함량의 증가를 나타내었다. 장뇌삼의 경우도 고압효소 분해 후 열수추출 대비 총 ginsenoside 함량이 4, 5 및 6년근에 있어 각각 25.3, 21 및 14.7% 증가한 결과를 보였다. 수삼 5년근에 있어 총 ginsenoside 함량이 46.9%로 증가한 결과는 홍삼 원료가 함유하고 있는 15.38%를 기준으로 비교할 때 99.3% 이상을 함유하는 것으로서, 홍삼제조 공정을 거치지 않고 수삼을 원료로 하여 홍삼과 거의 동일한 ginsenoside 함량을 갖는 인삼 분해물을 제조할 수 있는 장점으로 볼 수 있다. 즉, [표 9]를 참조하면, 열수추출 9.52% 대비 고압효소분해 13.99%를 비교할 때 46.9%로 증가하여 고압효소분해가 열수추출보다 총 ginsenoside 추출율이 높고, 표 9의 5년근 홍삼과 비교해도 높은 ginsenoside 함량을 보이는 결과를 알 수 있다. 따라서 본 발명에서 제안하는 고압효소분해에 의한 인삼분해물 제조는 홍삼 제조시 제조공정에 투입되는 열에너지 및 제조시간 등을 고려할 때 생산성 향상과 제조비용 감소효과를 제공하는 경제적인 녹색기술로 산업적 활용 가능성이 있는 기술이라고 판단된다.The ginsenoside contents after autoclaving of fresh ginseng, red ginseng and camphor ginseng are shown in [Table 9]. Comparing the total ginsenoside content of hot ginseng extracts after hydrolysis of fresh ginseng showed 17.6, 46.9, and 13.7% increase in 4, 5, and 6 years old roots, respectively. The total ginsenoside content was increased to 10.8 and 2.8%. In case of camphor ginseng, total ginsenoside contents were increased by 25.3, 21, and 14.7% in 4, 5 and 6 years, respectively, compared to hot water extraction after autolysis. The total ginsenoside content increased to 46.9% in 5 years of fresh ginseng, which contained more than 99.3% compared to 15.38% of red ginseng raw materials. It can be seen as an advantage to prepare a ginseng decomposition product having the same ginsenoside content. That is, referring to [Table 9], the total ginsenoside extraction rate is higher than that of hot water extraction, which is 46.9% when compared to 9.52% of hot water extraction compared to 13.99% of high pressure enzyme digestion. The results show high ginsenoside content. Therefore, the production of ginseng decomposed by high-pressure enzymatic decomposition proposed in the present invention is an economical green technology that provides productivity and reduction of manufacturing cost in consideration of thermal energy and manufacturing time input to the manufacturing process of red ginseng, which has the potential for industrial application. It is judged that it is technology.
수삼의 고압효소 분해후 ginsenoside 함량변화를 유추하기 위하여 인삼 분해물의 분자구조를 분석한 결과 고압효소 분해과정을 거친 후 새로운 분자구조의 화합물이 형성된 것을 확인할 수 있으며, 예상되는 화합물은 다음과 같다.As a result of analyzing the molecular structure of ginseng digestion to infer the change of ginsenoside content after autolysis of fresh ginseng, it was confirmed that a new molecular structure was formed after high pressure enzymatic digestion. The expected compounds are as follows.
1) 분자식 C12H24O12 1) Molecular Formula C 12 H 24 O 12
2) 분자식 C11H20O10 2) Molecular formula C 11 H 20 O 10
가) 나) 다) ABC)
3) 분자식 C6H12O6 3) Molecular formula C 6 H 12 O 6
가) 나) 다) ABC)
4) 분자식 C42H58O15 4) Molecular Formula C 42 H 58 O 15
가) 나) Ghana)
5) 분자식 C42H58O15 5) Molecular formula C 42 H 58 O 15
가) 나) Ghana)
Claims (4)
효소를 상기 고압반응기에 첨가하는 단계; 및
상기 고압반응기의 온도를 55℃ 내지 60℃로 조절하면서, 압력을 100MPa 내지 200MPa로 조절하여 24시간 내지 48시간 동안 인삼류 유용성분을 추출하는 단계;를 포함하며,
상기 효소가 상기 수삼 100중량부를 기준으로 보리엿기름 추출액 0.1 내지 3중량부, 터마밀 0.1 내지 3중량부, 비스코자임 0.1 내지 3중량부 및 셀루클라스트 0.1 내지 3중량부로 이루어짐을 특징으로 하는 고압효소분해에 의한 인삼류 유용성분의 추출방법.
Adding 20 parts by weight to 30 parts by weight of fresh ginseng based on 100 parts by weight of water and 100 parts by weight of water to the high pressure reactor;
Adding an enzyme to the autoclave; And
And extracting useful ingredients of ginseng for 24 hours to 48 hours by adjusting the pressure of the high pressure reactor to 55 ° C. to 60 ° C., and adjusting the pressure to 100 MPa to 200 MPa.
High-pressure enzyme, characterized in that the enzyme consists of 0.1 to 3 parts by weight of barley syrup oil extract, 0.1 to 3 parts by weight of teramyl, 0.1 to 3 parts by weight of biskozyme and 0.1 to 3 parts by weight of cellulose cellulose based on 100 parts by weight of the fresh ginseng. Extraction method of useful components of ginseng by decomposition.
상기 수삼 100중량부를 기준으로 효소의 총함량이 0.6중량부이며,
상기 고압반응기가 55℃ 온도조건 및 100MPa의 압력에서 24시간 동안 고압효소분해 반응을 실시함을 특징으로 하는 고압효소분해에 의한 인삼류 유용성분의 추출방법.The method of claim 1,
The total content of the enzyme is 0.6 parts by weight based on 100 parts by weight of the fresh ginseng,
Method for extracting useful components of ginseng by high pressure enzyme decomposition, characterized in that the high pressure reactor performs a high pressure enzyme decomposition reaction for 24 hours at 55 ℃ temperature conditions and pressure of 100MPa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110092204A KR101328413B1 (en) | 2011-09-09 | 2011-09-09 | An extracting method of ginseng by high pressure/enzyme decomposition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110092204A KR101328413B1 (en) | 2011-09-09 | 2011-09-09 | An extracting method of ginseng by high pressure/enzyme decomposition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130028564A KR20130028564A (en) | 2013-03-19 |
KR101328413B1 true KR101328413B1 (en) | 2013-11-14 |
Family
ID=48179046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110092204A KR101328413B1 (en) | 2011-09-09 | 2011-09-09 | An extracting method of ginseng by high pressure/enzyme decomposition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101328413B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190130714A (en) | 2018-05-15 | 2019-11-25 | 농업회사법인 에스에스바이오팜 주식회사 | Extraction method of silk peptide by enzymatic hydrolysis under ultra high pressure |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101592457B1 (en) * | 2013-10-30 | 2016-02-11 | 명지대학교 산학협력단 | Method for producing ginseng extract |
KR101643245B1 (en) * | 2014-11-25 | 2016-07-29 | 원광대학교산학협력단 | Composition containing Gastrodia elata Blume by high pressure/enzyme dissolution decomposion for improving blood circulation |
KR101661535B1 (en) * | 2015-12-28 | 2016-10-06 | 명지대학교 산학협력단 | Method for producing ginseng extract |
KR101935565B1 (en) * | 2016-06-15 | 2019-04-03 | (주)한국바이오엔지니어링 | Producing method for a water-soluble acidic polysaccharides derived from ginseng baeyanggeun using the Non-catalytic high-temperature hydrolysis and anti-solvent precipitation part |
KR102048833B1 (en) | 2017-11-14 | 2019-11-27 | 대한민국 | Method for preparing extract of Ginger comprising High Pressure/Enzymatic reaction step and Active ingradients increased Ginger extract prepared by the same |
KR101976998B1 (en) * | 2018-10-18 | 2019-05-10 | 한국수목원관리원 | The method for preparing a Platycodon grandiflorum extract using a high pressure enzyme treatment and a composition having antioxidant or α-glucosidase inhibiting activity |
KR102159806B1 (en) | 2018-12-14 | 2020-09-24 | 대한민국 | Method for preparing extract of ginger comprising ethanol treatment and active ingredients increased Ginger extract prepared by the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060066524A (en) * | 2004-12-13 | 2006-06-16 | 한국식품연구원 | Ginseng sauce and preparation method of ginseng sauce |
KR20090086806A (en) * | 2008-02-11 | 2009-08-14 | 주식회사 비티씨 | Method for preparing extract of ginseng using ultra high pressure |
-
2011
- 2011-09-09 KR KR1020110092204A patent/KR101328413B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060066524A (en) * | 2004-12-13 | 2006-06-16 | 한국식품연구원 | Ginseng sauce and preparation method of ginseng sauce |
KR20090086806A (en) * | 2008-02-11 | 2009-08-14 | 주식회사 비티씨 | Method for preparing extract of ginseng using ultra high pressure |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190130714A (en) | 2018-05-15 | 2019-11-25 | 농업회사법인 에스에스바이오팜 주식회사 | Extraction method of silk peptide by enzymatic hydrolysis under ultra high pressure |
Also Published As
Publication number | Publication date |
---|---|
KR20130028564A (en) | 2013-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101328413B1 (en) | An extracting method of ginseng by high pressure/enzyme decomposition | |
Mizuno et al. | Maitake, Grifola frondosa: pharmacological effects | |
KR101423100B1 (en) | Fabrication method of enhancing ginsenoside Rg3 and Rb1 of red ginseng | |
KR101343038B1 (en) | Fermented corn protein hydrolysate and preparing method thereof | |
KR101164529B1 (en) | Ginseng fermentation system for Ginsenoside increase | |
KR20170061959A (en) | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption | |
US20220322718A1 (en) | Active polysaccharide compound nutrient capable of enhancing immunity and resisting fatigue and preparation method therefor | |
KR20110105287A (en) | Manufacturing method of fermentative red ginseng | |
KR20110111142A (en) | Processing method of ginseng for enhancing contents of active components in the ginseng | |
KR101597877B1 (en) | Extracting method of effective component from ginsenosides | |
KR101846713B1 (en) | A method of preparing fermented laminaria japonica having anti-inflammatory | |
KR101372400B1 (en) | A manufacturing method of red ginseng staf4h with enhanced trace ginsenoside | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
KR101512841B1 (en) | Method for enzyme-treated fermented red ginseng extract, enzyme-treated fermented red ginseng extract and food composition comprising the extract | |
KR101934789B1 (en) | Method for preparing fermentation products of Panax ginseng flower improved contents of low molecular gingenosides and cosmetic compositions comprising fermentation products of Panax ginseng flower prepared thereby | |
KR20200078171A (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
KR101088711B1 (en) | A composition for prevention or alleviation of obesity containing Astragalus membranaceus extract manufactured by using enzymatic hydrolysis | |
KR101772894B1 (en) | Manufacturing method of Aloe polysaccharide using steam | |
KR101583573B1 (en) | Manufacturing method of red ginseng by multistage heating | |
KR20150051811A (en) | Composition containing ginseng extract and ginseng fruit extract | |
KR101975018B1 (en) | Composition for lowering cholesterol comprising a mixture culture of Ginseng Berry-Auricularia auricula mycelia | |
KR101365901B1 (en) | The method of preparing liguid engyme concentrated by extraction using cereal's embryobuds for soybean sauce | |
KR101877225B1 (en) | Method for Manufacturing Tablet Containing Fermented Ginseng and Maca | |
KR20080044942A (en) | Ginseng preparations containing a high concentration of ginseng sapogenin using a bacillus natto and method thereof | |
KR101889733B1 (en) | Lotus root grain syrup, and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20161024 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20181108 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20191105 Year of fee payment: 7 |